Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M37.4Revenue (TTM) $M--Net Margin (%)--Altman Z-Score--
Enterprise Value $M-15.3EPS (TTM) $-2.1Operating Margin %--Piotroski F-Score3
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yY
Price/Book0.810-y EBITDA Growth Rate %--Quick Ratio14.0Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio14.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-48.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-52.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M15.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NVLS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

NVLS is held by these investors:



NVLS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIOTECHNOLOGY VALUE FUND L P 2017-06-20Buy17,806$2.253.11view
BIOTECHNOLOGY VALUE FUND L P 2017-06-07Buy72,650$2.291.31view
BIOTECHNOLOGY VALUE FUND L P 2017-05-31Buy47,000$2.272.2view
BIOTECHNOLOGY VALUE FUND L P 2017-05-19Buy78,858$2.30.87view
BIOTECHNOLOGY VALUE FUND L P 2017-05-11Buy109,034$2.320view
CONWAY ROBERT EDirector 2017-05-09Buy5,000$2.34-0.85view
CONWAY ROBERT EDirector 2017-05-08Buy15,000$2.281.75view
TROHA JANICEExec Vice President / COO 2017-05-05Buy10,000$2.34-0.85view
CONWAY ROBERT EDirector 2017-05-05Buy20,000$2.30.87view
CONWAY ROBERT EDirector 2017-05-04Buy10,000$2.262.65view

Quarterly/Annual Reports about NVLS:

News about NVLS:

Articles On GuruFocus.com

More From Other Websites
Nivalis Therapeutics, Inc. Sets Date for Special Meeting of Stockholders Jun 02 2017
Shire (SHPG) Beats on Q1 Earnings & Sales, Reiterates View May 03 2017
AMAG Pharma (AMAG) Incurs Loss in Q1, Revenues Rise Y/Y May 03 2017
Nivalis Therapeutics reports 1Q loss May 01 2017
Nivalis Therapeutics Reports First Quarter 2017 Financial Results May 01 2017
What's in Store for Nivalis (NVLS) this Earnings Season? Apr 26 2017
Nivalis' (NVLS) Shares Down After Merger Deal with Alpine Apr 20 2017
Colorado biotech firm is being acquired to create $90M company in Seattle Apr 18 2017
Former Dendreon CEO Mitch Gold Returns to Public Biotech Stage with Cancer Immunotherapy Merger Apr 18 2017
Nivalis Therapeutics, Inc. and Alpine Immune Sciences, Inc. Agree to Combine Apr 18 2017
Vertex Pharma Cystic Fibrosis Combo Succeeds (VRTX) Mar 29 2017
Antares Pharma Inc. and Nivalis Therapeutics Inc. Show Resiliency as They Snap Back from Late 2016... Mar 15 2017
Here’s What Happened With Cyclacel Pharmaceuticals Inc (CYCC) And Nivalis Therapeutics Inc (NVLS) Feb 24 2017
BioLineRx (BLRX) Starts Cancer Study on BL-8040+Keytruda Jan 19 2017
Here’s What Happens Now At Nivalis Therapeutics Inc (NVLS) Jan 16 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}